tiprankstipranks
Biogen, Eisai’s Alzheimer’s Drug Scores Big With FDA’s Full Approval
PremiumMarket NewsBiogen, Eisai’s Alzheimer’s Drug Scores Big With FDA’s Full Approval
1y ago
Eisai, Biogen say lecanemab received Priority Review status in Japan
Premium
The Fly
Eisai, Biogen say lecanemab received Priority Review status in Japan
2y ago
Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer’s disease
Premium
The Fly
Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer’s disease
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100